BackArena Pharmaceuticals Overview

Arena Pharmaceuticals EBIT

EBIT (Earnings Before Interest and Taxes) analysis for ARNA.

Quarterly EBIT

-$151.37M
↓ 11.88% YoY

As of Dec 31, 2021

Annual EBIT (TTM)

-$552.24M
↓ 29.44% YoY

Trailing 12 months ending Dec 31, 2021

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin